High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade.
Nat Med
; 26(5): 693-698, 2020 05.
Article
in En
| MEDLINE
| ID: mdl-32405063
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Interleukin-8
/
B7-H1 Antigen
/
Antineoplastic Agents, Immunological
/
Neoplasms
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Nat Med
Journal subject:
BIOLOGIA MOLECULAR
/
MEDICINA
Year:
2020
Type:
Article
Affiliation country:
United States